October 7, 2024Virios Therapeutics, Inc. • October 7th, 2024 • Pharmaceutical preparations • Delaware
Company FiledOctober 7th, 2024 Industry JurisdictionIn connection with the Share Exchange Agreement relating to Pharmagesic (Holdings) Inc., a Canadian corporation, by and between Virios Therapeutics, Inc., a Delaware corporation (the “Company”), and Sealbond Limited, a British Virgin Islands corporation (the “Transaction”), the Company hereby enters into this Letter Agreement with CK Life Sciences Int’l., (Holdings) Inc. (the “Investor”).
October 7, 2024Virios Therapeutics, Inc. • October 7th, 2024 • Pharmaceutical preparations • Delaware
Company FiledOctober 7th, 2024 Industry JurisdictionIn connection with the Share Exchange Agreement relating to Pharmagesic (Holdings) Inc., a Canadian corporation, by and between Virios Therapeutics, Inc., a Delaware corporation (the “Company”), and Sealbond Limited, a British Virgin Islands corporation (the “Transaction”), the Company hereby enters into this Letter Agreement with CK Life Sciences Int’l., (Holdings) Inc. (the “Investor”).